Post-Implant Phosphodiesterase-5 Inhibitors in Patients with Left Ventricular Assist Device: A Systematic Review and Meta-Analysis

Background: Despite the improvement in left ventricular assist device (LVAD) technology and the advent of third-generation LVADs, hemocompatibility-related events remain a significant issue. Therefore, new pharmacological treatments are necessary to optimize patient management and to further reduce...

Descripción completa

Detalles Bibliográficos
Autores principales: Xanthopoulos, Andrew, Magouliotis, Dimitrios E., Tryposkiadis, Konstantinos, Zotos, Prokopis-Andreas, Spiliopoulos, Kyriakos, Athanasiou, Thanos, Giamouzis, Grigorios, Skoularigis, John, Starling, Randall C., Triposkiadis, Filippos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604415/
https://www.ncbi.nlm.nih.gov/pubmed/36294308
http://dx.doi.org/10.3390/jcm11205988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604415/
https://www.ncbi.nlm.nih.gov/pubmed/36294308
http://dx.doi.org/10.3390/jcm11205988

Ejemplares similares